**Core Concept**
Caroli's disease is a rare **genetic disorder** characterized by non-obstructive dilatation of the **intrahepatic bile ducts**. This condition is associated with an increased risk of **cholangitis** and **cholangiocarcinoma**. The underlying principle involves abnormalities in **bile duct morphogenesis**.

**Why the Correct Answer is Right**
The correct answer choice is not provided, however, Caroli's disease is known to be a congenital disorder involving the **intrahepatic bile ducts**, leading to their dilatation. This condition can be associated with **polycystic kidney disease** and other **fibropolycystic diseases**. The disease is thought to result from a defect in the **remodeling of the ductal plate** during embryonic development.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not provided, however, any option that does not accurately describe Caroli's disease as a condition involving the **intrahepatic bile ducts** would be incorrect.
**Option B:** Similarly, this option is not provided, but an incorrect option might describe a different condition or location, such as **extrahepatic bile ducts**.
**Option C:** Again, without the specific option, any choice that does not align with the **pathophysiology** or **clinical presentation** of Caroli's disease would be incorrect.
**Option D:** This option is also not provided, but it would be incorrect if it described a condition unrelated to **bile duct dilatation** or **congenital hepatic disorders**.

**Clinical Pearl / High-Yield Fact**
Caroli's disease is a notable cause of **recurrent cholangitis** and has an increased risk of **malignant transformation**. Recognizing the condition's association with **congenital hepatic fibrosis** and **polycystic kidney disease** is crucial for comprehensive management.

**Correct Answer:** D. Congenital dilatation of intrahepatic bile ducts